BIT Capital GmbH Buys 47,592 Shares of Oscar Health, Inc. (NYSE:OSCR)

Key Points

• BIT Capital GmbH increased its stake in Oscar Health, acquiring an additional 47,592 shares, bringing their total holdings to 4,521,445 shares, representing about 5.1% of their investment portfolio.
• Oscar Health recently reported $0.92 earnings per share for the quarter, exceeding analysts' expectations of $0.83, while the company generated $3 billion in revenue, up 42.2% year-over-year.
• Oscar Health stock has seen analyst ratings shift, with five ratings categorized as sell and five as hold, reflecting varied investor sentiment on its future performance.

BIT Capital GmbH raised its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 1.1% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,521,445 shares of the company's stock after acquiring an additional 47,592 shares during the period. Oscar Health makes up 5.1% of BIT Capital GmbH's investment portfolio, making the stock its 3rd largest position. BIT Capital GmbH owned about 1.80% of Oscar Health worth $59,276,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of OSCR. Tempus Wealth Planning LLC grew its holdings in Oscar Health by 6.7% during the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock valued at $189,000 after purchasing an additional 906 shares during the period. Xponance Inc. boosted its stake in shares of Oscar Health by 7.1% in the first quarter. Xponance Inc. now owns 15,423 shares of the company's stock worth $202,000 after acquiring an additional 1,029 shares during the period. CWM LLC boosted its stake in shares of Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after acquiring an additional 1,078 shares during the period. Summit Investment Advisors Inc. boosted its stake in shares of Oscar Health by 5.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock worth $280,000 after acquiring an additional 1,141 shares during the period. Finally, Oppenheimer & Co. Inc. grew its holdings in Oscar Health by 4.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock valued at $372,000 after buying an additional 1,250 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Stock Up 5.6%

Shares of NYSE OSCR traded up $0.80 during mid-day trading on Thursday, hitting $15.14. The company had a trading volume of 13,779,357 shares, compared to its average volume of 13,103,433. The company has a market capitalization of $3.86 billion, a PE ratio of 54.16 and a beta of 1.86. The business's 50-day simple moving average is $15.84 and its 200 day simple moving average is $14.87. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.88 and a quick ratio of 0.88. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The business had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the prior year, the business posted $0.20 EPS. The company's revenue for the quarter was up 29.0% on a year-over-year basis. On average, analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insider Activity

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the transaction, the director directly owned 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 24.39% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Barclays reduced their price target on Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a report on Wednesday, July 23rd. Piper Sandler cut Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective for the company. in a research report on Monday, July 14th. Baird R W cut Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Wells Fargo & Company cut Oscar Health from an "equal weight" rating to an "underweight" rating and lowered their price target for the stock from $16.00 to $10.00 in a research report on Friday, July 11th. Finally, UBS Group reaffirmed a "sell" rating and set a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Five investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the company's stock. According to data from MarketBeat.com, Oscar Health currently has an average rating of "Hold" and an average price target of $12.21.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.